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Background: To examine age-speciﬁc differences in the frequency and impact of cardiac and non-cardiac conditions
among patients aged 65 years and older hospitalized with acute myocardial infarction (AMI).
Methods: Study population consisted of 3863 adults hospitalized with AMI at 11 medical centers in central
Massachusetts on a biennial basis between 2001 and 2011. The presence of 11 chronic conditions (ﬁve cardiac
and six non-cardiac) was based on the review of hospital medical records.
Results: Participants' median age was 79 years, 49% were men, and had an average of three chronic conditions
(average of cardiac conditions: 2.6 and average of non-cardiac conditions: 1.0). Approximately one in every two
patients presented with two or more cardiac related conditions whereas one in every three patients presented with
two or more non-cardiac related conditions. The most prevalent chronic conditions in our study population were
hypertension, diabetes, heart failure, chronic kidney disease, and peripheral vascular disease. Patients across all age
groups with a greater number of previously diagnosed cardiac or non-cardiac conditions were at higher risk for
developing important clinical complications or dying during hospitalization as compared to thosewith 0–1 condition.
Conclusions: The prevalence of multimorbidity among older adults hospitalized with AMI is high and associated with
worse outcomes that should be considered in the management of this vulnerable population.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
The prevalence of multiple coexistent chronic conditions (MCCs) in
patients with cardiovascular disease has become increasingly common,
especially as the U.S. and other industrialized populations age. Patients
hospitalizedwith an acutemyocardial infarction (AMI) andMCCs expe-
rience higher levels of healthcare use and suffer poorer health related
outcomes than those without MCCs [1–8]. The clinical management of
persons hospitalized with an AMI and MCCs is particularly challenging,
due in part to their high risk for adverse events, as well as the need for
complex and tailored therapeutic regimens [9].
Despite the high prevalence of MCCs in patients hospitalized for
AMI, especially among older individuals, there are relatively limited
contemporary data describing the magnitude of MCCs in older adults
of different ages hospitalized with AMI, and possible age-speciﬁc dif-
ferences in the effects of cardiac and non-cardiac related conditions on
the risk of developing important clinical complications and dying
during hospitalization for AMI [10–12].
The purpose of this large observational study was to describe the
magnitude of cardiac and non-cardiac related multimorbidity, among
older adults in three age strata (65–74, 75–84 and 85 years and older)
hospitalized at all 11 central Massachusetts medical centers with AMI,
and to examine the association between burden of cardiac and non-
cardiac conditionswith the risk of developing various adverse outcomes
during admission to the hospital for AMI. Data from the population-
based Worcester Heart Attack Study were used for purposes of this
investigation [13–16].
2. Materials and methods
The Worcester Heart Attack Study is an ongoing population-based investigation that
is examining long-term trends in the clinical epidemiology of AMI among residents of
theWorcester, Massachusetts (MA), metropolitan area hospitalized at all medical centers
in central MA on an approximate biennial basis [13–17].
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Computerized printouts of residents of central MA discharged from all 11 greater
Worcester hospitals with possible AMI [International Classiﬁcation of Disease (ICD) 9
codes 410–414, and 786.5] on a biennial basis between 2001 and 2011 were identiﬁed.
Cases of possible AMI were independently validated using predeﬁned criteria for AMI,
including diagnoses of ST segment elevation myocardial infarction (STEMI) and non-ST
segment elevation myocardial infarction (NSTEMI) [18,19]. This study was approved by
the Institutional Review Board at the University of Massachusetts Medical School.
Trained nurses and physicians abstracted information on patient's demographic and
clinical characteristics and hospital treatment practices and outcomes through the review
of hospital medical records. These characteristics included patient's age, sex, race/ethnicity,
hospital length of stay, and 11 previously diagnosed chronic conditions. These 11 chronic
conditions were further classiﬁed into two groups: ﬁve Cardiac related conditions: atrial
ﬁbrillation, heart failure, hypertension, peripheral vascular disease, and stroke; and six
Non-cardiac related conditions: anemia, asthma/chronic pulmonary disease, chronic
kidney disease, dementia/Alzheimer, depression, and diabetes. Information on the
development of important in-hospital complications including atrial ﬁbrillation [20],
cardiogenic shock [21], heart failure [22], stroke [23], and dyingwas collected through the
review of hospital medical records. Data on the receipt of three coronary diagnostic and
interventional procedures [cardiac catheterization, percutaneous coronary intervention
(PCI), and coronary artery bypass graft surgery (CABG)] during hospitalization,
and evidence-based pharmacotherapies during hospitalization, namely angiotensin
converting inhibitors (ACE-I)/angiotensin receptor blockers (ARBs), aspirin, beta-
blockers, and lipid lowering agents were also obtained.
2.1. Data analysis
We stratiﬁed our study population into three age groups for purposes of contrast and
analysis, namely those 65–74 years old, 75–84 years old, and persons 85 years and older.
We compared differences in the baseline demographic and clinical characteristics, hospital
management practices, and in-hospital outcomes within each of these three age strata
using chi square tests for categorical variables and the ANOVA test for continuous variables.
We estimated the overall prevalence of the ﬁve cardiac and six non-cardiac related condi-
tions and, based on the previous literature [24], included in this study any morbidity with
a prevalence ≥5% in this patient population.
For purposes of more systematically examining the association between the number
of cardiac and non-cardiac conditions previously diagnosed with the risk of dying or
developing any of the examined important clinical complications (heart failure, stroke,
cardiogenic shock, or atrial ﬁbrillation) during hospitalization for AMI (as a single com-
posite endpoint) among patients in the three age strata, we used logistic regression
modeling and we adjusted for several potentially confounding demographic and clinical
factors of prognostic importance in these models. These factors were chosen based on
ﬁndings from prior studies and on their clinical importance. The variables we controlled
for included sex, type of AMI (STEMI vs NSTEMI), AMI order (initial vs. prior), receipt of
the examined cardiac interventions (cardiac catheterization, percutaneous coronary
intervention, and coronary artery bypass graft surgery) and receipt of evidence- based
cardiacmedications during the index hospitalization (angiotensin converting enzyme
inhibitors/angiotensin receptor blockers, aspirin, beta blockers, and lipid lowering
medications). We created interaction terms between age and the number of chronic
conditions previously diagnosed to examine whether the association between MCCs
and the risk of developing our composite study endpoint differed according to age. We
used likelihood ratio tests to compare models with and without our interaction terms.
3. Results
A total of 3863 residents of central MA 65 years and older were
hospitalized with an independently validated AMI at all 11 greater
Worcester medical centers during the six study years between 2001
and 2011. The median age of this patient population was 79 years and
48.9% were men. The average number of previously diagnosed chronic
conditions in this population was 3.1 while the median was 3.0. The
average number of cardiac conditions was 2.6 while the average
number of non-cardiac conditions was 1.0.
3.1. Baseline characteristics according to patient's age at
hospital presentation
Patients aged 75–84 years old were more likely to have been diag-
nosed with a NSTEMI and to have had a previously diagnosed AMI as
compared with those 65–74 years old (Table 1). Patients 85 years and
olderweremore likely to bewomen, Caucasian, to have been diagnosed
with an NSTEMI, and to have presented with a previous AMI as com-
pared with those aged 65–74 years old (Table 1).
Frequency of chronic conditions according to patient's age at hospital
presentation.
Patients 75–84 years old and those 85 years and older were more
likely to have been previously diagnosed with almost every one of the
11 chronic conditions examined in this study, with the exception
of chronic pulmonary disease/asthma and diabetes, as compared with
patients 65–74 years old (Table 1). The most prevalent chronic condi-
tions in patients 65–74 years old were hypertension, diabetes, chronic
pulmonary disease/asthma, heart failure, and peripheral vascular
disease whereas the most prevalent chronic conditions among patients
75–84 years old were hypertension, heart failure, diabetes, chronic lung
disease/asthma, and chronic kidney disease; similar disease patterns
were found in patients 85 years and older. Almost one of every two
patients across all age groups presented with two or more cardiac
related conditions, whereas almost one in every three patients
presented with two or more non-cardiac related conditions (Table 1).
3.2. In-hospital complications according to patient's age
Patients aged 75–84 years and those 85 years and older were more
likely to have developed atrial ﬁbrillation and heart failure during their
index hospitalization for AMI as compared with those in the youngest
age group. Approximately one in every six patients 65–74 years old,
one in every ﬁve among those 75–84 years, and one in every four pa-
tients 85 years and older developed two or more serious in-hospital
complications (Table 1).
3.3. Differences in hospitalmanagement practices according to patient's age
and comorbidity burden
The proportion of patients aged 85 years and older who received all
four evidence- basedmedications during their acute hospitalizationwas
Table 1
Patient demographic and clinical characteristics according to age among patients hospital-
ized with acute myocardial infarction.
Characteristic 65–74 years
(n = 1186)
(%)
75–84 years
(n = 1540)
(%)
≥85 years
(n = 1137)
(%)
Age (mean, years) 69.8 79.7 88.5⁎⁎
Male 59.5 49.9 36.4⁎⁎
White 86.9 93.1 95.5⁎⁎
Non ST-segment myocardial infarction 68.7 75.1 78.7⁎⁎
Initial myocardial infarction 61.9 59.9 59.2
Do not resuscitate order 12.9 29.4 61.4⁎⁎
Medical history
Anemia 8.9 13.8 19.1⁎⁎
Atrial ﬁbrillation 11.8 20.5 26.8⁎⁎
Chronic kidney disease 21.3 23.6 29.7⁎⁎
Chronic lung disease/asthma 26.0 24.9 20.6⁎
Dementia/Alzheimer 0.7 4.7 9.2⁎⁎
Depression 14.5 16.7 17.8
Diabetes mellitus 45.5 39.7 27.1⁎⁎
Heart failure 23.2 30.5 38.4⁎⁎
Hypertension 79.5 80.5 81.5
Peripheral vascular disease 22.9 22.5 20.4
Stroke 11.5 16.9 14.7⁎⁎
Cumulative number of morbidities
Cardiac related
2 or more 41.9 52.5 56.3⁎⁎
Non-cardiac related
2 or more 29.9 34.0 36.6⁎
In-hospital clinical complications
Atrial ﬁbrillation 19.6 28.3 31.2⁎⁎
Cardiogenic shock 6.7 6.2 4.9
Heart failure 47.1 53.1 63.1⁎⁎
Stroke 2.3 2.0 2.5
Death 8.3 12.9 14.9⁎⁎
No complications 43.1 34.6 25.8⁎⁎
Any 1 complication 41.1 44.3 49.6⁎⁎
Any 2 or more complications 15.9 21.2 24.6⁎⁎
⁎ Signiﬁcant at p b 0.05.
⁎⁎ Signiﬁcant at p b 0.001.
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signiﬁcantly lower as compared with those 65–74 years and those 75–
84 years old (Table 2). The percentage of patients that received any
diagnostic/interventional procedurewas signiﬁcantly lower in patients
85 years and older as compared with those 65–74 years and those
75–84 years old.
The proportion of patients aged 85 years and older who presented
with two or more cardiac or non-cardiac related conditions who were
treated with all four evidence- based medications during their acute
hospitalization was signiﬁcantly lower as compared with those who
presented with fewer chronic conditions within the same age group
(Table 3 A). The percentage of patients that received any diagnostic/
interventional procedure was signiﬁcantly lower across all age groups
in thosewhopresentedwith two ormore cardiac or non-cardiac related
conditions, and this proportion was noticeably lowest in those aged
85 years and older who presented with two or cardiac or non- cardiac
related conditions (Table 3 B).
3.4. Multimorbidity and the risk of adverse hospital outcomes according to
patient's age
After controlling for several potentially confounding demographic
and clinical factors of prognostic importance, we found an increased
risk of dying or developing any of the examined important clinical
complications, namely AF, HF, stroke or cardiogenic shock, during
hospitalization according to thenumber of previously diagnosed cardiac
and non-cardiac chronic conditions across all age groups (Table 4).
4. Discussion
The results of this population-based observational study in nearly
4000 adults 65 years and older from a large central New England metro-
politan area hospitalized with AMI suggest a high burden of cardiac and
non-cardiac related conditions in these patients. Moreover, we observed
an association between the presence of multiple cardiac and non-
cardiac multimorbidities with the risk of developing important hospital
clinical complications or dying during the patient's acute hospitalization.
4.1. Magnitude of multiple chronic conditions according to advanced age
Our results are consistent with the ﬁndings from previous studies
which have shown that older patients (≥65 years) have a high burden
of MCCs [24–27]. The most prevalent chronic conditions in our study
population were hypertension, diabetes, heart failure, chronic kidney
disease, and peripheral vascular disease.
Somewhat similar patterns of MCCs were found in a cross-sectional
study of N1,750,000 ambulatory men and women who were treated at
N300 Scottish general practices during 2007 [25]. Approximately one
quarter of the study population aged 65–74 years presented with two
or more chronic conditions whereas the proportion of persons
75 years and older with two or more conditions was 45% and 54%,
respectively [25]. In the Swiss FIRE (Family Medicine ICPC Research
using Electronic Medical Record) study of N98,000 adults enrolled in
the Swiss healthcare system between 2009 and 2011, the prevalence
of multimorbidity (two or more chronic conditions) increased with
advancing age: 26% of those aged 60–69 years, 34% of those aged 70–
79, and 38% in persons 80 years and older [27].
A limited number of prior studies have examined the magnitude
and/or impact ofMCCs at the time of hospitalization for AMI in different
age strata [4,5,12,28]. Among nearly 17,000 patients diagnosed with a
NSTEMI at 125 medical centers in Victoria, Australia between 2007
and 2009 (mean age = 75 years) [27], multimorbidity was more
prevalent with advancing age; the prevalence of three or more chronic
conditions among individuals aged b60, 60–74, and ≥75 years was
18%, 37%, and 46%, respectively [28].
Our population-based study builds on a limited prior literature
showing that the proportion of elderly persons who present with
Table 3
A and B: Hospital management practices according to age and the frequency of cardiac and non-cardiac related conditions.
65–74 years n = 1186 75–84 years n = 1540 ≥85 years n = 1137
Only 2
medications
Only 3
medications
All 4
medications
Only 2
medications
Only 3
medications
All 4
medications
Only 2
medications
Only 3
medications
All 4
medications
Cardiac related
0–1 13.6 29.3 57.0 20.9 29.6 49.5 25.8 29.8 44.5
2 or more 14.1 32.2 53.7 18.2 31.1 50.7 29.7 33.8 36.6
Non cardiac-related
0–1 12.8 30.8 56.4 19.9 30.4 49.7 29.0 30.4 40.6
2 or more 16.3 29.9 53.8 18.7 30.3 51.0 26.2 34.9 38.9
65–74 years n = 1186 75–84 years n = 1540 ≥85 years n = 1137
No procedures CABG or PCI No procedures CABG or PCI No procedures CABG or PCI
Cardiac related
0–1 33.8 66.2 51.9 48.1 78.7 21.3
2 or more 58.6 41.5 67.6 32.4 88.6 11.4
Non cardiac-related
0–1 36.6 63.4 54.5 45.5 80.9 19.1
2 or more 62.0 38.0 71.0 29.0 90.1 9.9
Table 2
Hospital management practices according to age among patients hospitalized with acute
myocardial infarction.
65–74 years
(n = 1186)
(%)
75–84 years
(n = 1540)
(%)
≥85 years
(n = 1137)
(%)
Diagnostic/interventional procedure
Cardiac catheterization 72.3 52.7 23.0⁎⁎
Coronary bypass surgery 10.3 6.6 0.7⁎⁎
Percutaneous coronary intervention 47.0 33.8 15.0⁎⁎
Either coronary bypass surgery or
percutaneous coronary intervention
55.8 39.9 15.7⁎⁎
Medications
Angiotensin converting enzyme inhibitors/
angiotensin receptor blockers
69.7 68.2 61.0⁎⁎
Aspirin 93.3 91.5 89.2⁎
Beta blockers 91.2 88.7 87.8⁎
Lipid lowering medications 80.5 73.1 61.4⁎⁎
Any 2 medications 13.8 19.5 28.0⁎⁎
Any 3 medications 30.5 30.4 32.0
All 4 medications 55.7 50.1 40.0⁎⁎
⁎ Signiﬁcant at p ≤ 0.05.
⁎⁎ Signiﬁcant at p ≤ 0.001.
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MCCs at the time of hospitalization for AMI is signiﬁcant. Since, how-
ever, there remains a lack of a gold standard on how to best deﬁne
and characterize multimorbidity, and a lack of consensus around
which diagnoses should be includedwhen counting chronic conditions,
further work remains needed on how to best assess and measure the
overall burden of multimorbidity and how MCCs impact the manage-
ment and clinical outcomes among older men and women hospitalized
with various acute manifestations of underlying chronic diseases.
4.2. Hospital medical management practices according to age
and multimorbidity
Our ﬁndings suggest that the proportion of older patients (85 years
and older) with two or more cardiac or non-cardiac related conditions
who received evidence- based cardiac medications and cardiac inter-
ventions was signiﬁcantly lower as compared with the younger
comparison groups.
Similar ﬁndings have been reported by other investigators [28–30].
A study of Medicare beneﬁciaries hospitalized with AMI reported that
the utilization rates of aspirin, beta blockers, and coronary reperfusion
therapy were lower in older elderly patients [29]. Data from the
National Hospital Discharge Survey examining AMI related hospitaliza-
tions in the U.S. between 1979 and 2005 showed that patients aged
85 years and older were the least likely to have undergone coronary
interventional procedures [30].
Published data on the effectiveness of various cardiac interventions
in older patients with MCCs according to age are surprisingly scarce,
although there is some evidence that suggests that elderly patients
might receive greater beneﬁts on survival from the receipt of these
therapies than younger old patients [31]. In our previous study of
1137 patients ≥85 years hospitalized between 1997 and 2007 for AMI
at all 11 metropolitan Worcester medical centers, the 90-day post-
discharge survival improved signiﬁcantly in these elderly patients
during the years under study and these encouraging trends were
primarily driven by the increased use of guideline-based cardiac medi-
cations [31]. Future clinical guidelines and pragmatic clinical trials
might beneﬁt from broadening their inclusion criteria to include elderly
men and women who present with MCCs in order that health care
providers can make better clinical management decisions about these
high-risk complex patients.
4.3. Risk of developing important clinical complications during hospitalization
for AMI according to age and number of chronic conditions
Our ﬁndings suggest that there was a signiﬁcantly increased risk of
developing any complication or dying during hospitalization for AMI
according to the number of cardiac and non-cardiac related conditions
across all age groups except in the association of non-cardiac conditions
and adverse outcomes in those individuals aged 85 and over. Of special
note, the association of non- cardiac related conditions and adverse
outcomes was especially prominent among those aged b75 years.
There might be several potential explanations for our ﬁndings. The
impact of MCCs may be different in younger versus older patients and
other factors may be better predictors of important clinical outcomes
in older adults with MCCs [32,33]. In the Health and Retirement Study,
(n= 19,000) as the age of study participants increased, the association
of MCCs and 1-year mortality was attenuated, whereas the association
of functional limitations and mortality remained strong [32].
Other risk factors, such as functional status, frailty, presence of care-
givers, or psychosocial factors might play a more important role in
predicting patient's short and/or long-term outcomes, including the
risk of dying after an acute coronary syndrome among the elderly
[32–36]. A study of Medicare enrollees showed that function-related
parameters (e.g., delirium/dementia, mobility limitations) were strongly
associated with the risk of dying within 12 months after hospital dis-
charge for AMI [34]. Coupledwith our ﬁndings, prior datawould support
the hypothesis thatMCCs, especially non-cardiac related conditions,may
have less of an impact on the development of adverse outcomes than
other factors including frailty, functional limitations, or psychosocial
impairments during hospitalization for AMI in men and women of dif-
ferent ages and with varying frequencies and types of MCCs [32].
4.4. Study strengths and limitations
This study has several strengths including its population-based
design that captured the vast majority of cases of AMI that occurred
among residents of central MA during the years under study. Several
limitations need to be kept inmind, however, in interpreting the present
ﬁndings. First, data on chronic conditions were abstracted from hospital
medical records and we did not have information available about the
duration, severity, or extent of these previously diagnosed conditions.
The majority of our study population was Caucasian and we did not
have information available on several patient associated characteristics
(e.g., socioeconomic status, functional status, and cognitive impairment)
which may have confounded the observed associations, and how these
factors may have differed according to age and presence of MCCs. We
restricted our study outcomes to the development of in-hospital events
to focus our analysis on the highest risk period for developing adverse
outcomes in older patients of different ages hospitalized for AMI and to
minimize the potentially confounding inﬂuence of other unmeasured
factors that might have developed after being discharged from the
hospital after an AMI.
5. Conclusions
The results of our study suggest that MCCs are highly prevalent and
impactful in elderly patients who are hospitalized for an AMI. Future
research investigations should examine the impact of various therapeutic
interventions in patients with AMI of different ages with MCCs on both
patient-centered and clinical outcomes to determine the best ways to
treat and monitor these high risk and complex patients and identify
Table 4
Risk of developing the composite study endpoint during hospitalization for an acute myocardial infarction according to age and frequency of cardiac and non-cardiac related conditions.
65–74 years (n = 1186) 75–84 years (n = 1540) ≥85 years (n = 1137)
Composite outcomec Unadjusted OR (95%CI) Adjusted ORs (95% CI) Unadjusted OR (95%CI) Adjusted ORs (95% CI) Unadjusted OR (95%CI) Adjusted ORsa (95% CI)
Cardiac relatedb
Chronic condition 2.99 (2.36;3.80) 2.09 (1.59;2.75) 2.05 (1.67;2.51) 1.62 (1.30;2.02) 1.98 (1.55;2.53) 1.81 (1.40;2.35)
Non-cardiac relatedb
Chronic condition 2.04 (1.34;3.10) 1.39 (1.04;1.86) 1.55 (1.14;2.10) 1.86 (1.47;2.36) 1.01 (0.72;1.41) 1.22 (0.93;2.60)
a Models adjusted for sex, type of AMI and order (initial vs. prior), receipt of all four evidence-based cardiac medications (e.g., Angiotensin converting enzyme inhibitors/Angiotensin
receptor blockers, Aspirin, Beta-blockers, Lipid loweringmedications) and either coronary artery bypass surgery or a percutaneous coronary intervention. In themodels inwhichwe used
cardiac-related conditions as a predictor of our composite study endpoint, we adjusted for the presence of non-cardiac related conditions and vice versa.
b Reference group are those individuals with 0–1 cardiac related or non-cardiac related chronic condition, respectively. A multiple chronic conditions variable, either cardiac or non-
cardiac related, has been included as a continuous variable scaled according to every two chronic condition.
c Composite outcome is a combination of any of the examined clinical complications (AF, HF, stroke, or cardiogenic shock) or death during hospitalization for AMI.
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those chronic conditions, singly and in combination, that are most
impactful.
Abbreviations
ACE-I angiotensin converting inhibitors
AMI acute myocardial infarction
ARBs angiotensin receptor blockers
CABG coronary artery bypass graft surgery
MCCs multiple chronic conditions
STEMI ST segment elevation myocardial infarction
NSTEMI non-ST segment elevation myocardial infarction
PCI percutaneous coronary intervention
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